Hong Peng

1.8k total citations
59 papers, 1.2k citations indexed

About

Hong Peng is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Hong Peng has authored 59 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 13 papers in Molecular Biology and 11 papers in Physiology. Recurrent topics in Hong Peng's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers), Neonatal Respiratory Health Research (10 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers). Hong Peng is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers), Neonatal Respiratory Health Research (10 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers). Hong Peng collaborates with scholars based in China, United States and Australia. Hong Peng's co-authors include Erica L. Herzog, Ping Chen, Hong Luo, Yan Chen, Xueyan Peng, Qinxue Shen, Shan Cai, Ting Guo, Robert Homer and Aditi Mathur and has published in prestigious journals such as Nature Communications, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Hong Peng

52 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hong Peng China 20 400 373 173 161 147 59 1.2k
Chengping Hu China 18 329 0.8× 381 1.0× 98 0.6× 222 1.4× 137 0.9× 50 1.2k
Shanping Jiang China 23 306 0.8× 419 1.1× 238 1.4× 283 1.8× 96 0.7× 54 1.4k
Katherine Ma O’Reilly Ireland 13 621 1.6× 193 0.5× 116 0.7× 91 0.6× 105 0.7× 33 1.1k
Alexandra C. Racanelli United States 10 334 0.8× 452 1.2× 131 0.8× 141 0.9× 139 0.9× 18 1.1k
Shijie Wang China 20 289 0.7× 507 1.4× 163 0.9× 85 0.5× 264 1.8× 104 1.4k
Mahmood Yaseen Hachim United Arab Emirates 22 184 0.5× 501 1.3× 323 1.9× 208 1.3× 281 1.9× 101 1.4k
Rui Tian China 20 235 0.6× 388 1.0× 113 0.7× 193 1.2× 121 0.8× 57 1.2k
Zeng‐Hong Wu China 15 294 0.7× 431 1.2× 110 0.6× 67 0.4× 148 1.0× 51 931
Bihong Zhao United States 17 158 0.4× 316 0.8× 271 1.6× 218 1.4× 248 1.7× 61 1.2k
Zongwen Shuai China 19 171 0.4× 446 1.2× 209 1.2× 388 2.4× 100 0.7× 81 1.5k

Countries citing papers authored by Hong Peng

Since Specialization
Citations

This map shows the geographic impact of Hong Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Peng more than expected).

Fields of papers citing papers by Hong Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Peng. The network helps show where Hong Peng may publish in the future.

Co-authorship network of co-authors of Hong Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Hong Peng. A scholar is included among the top collaborators of Hong Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong Peng. Hong Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yuan, Jiali, et al.. (2024). The Protective Impact of Gd-DTPA on Hemolysis in Pulsed Field Ablation for Atrial Fibrillation. JACC. Clinical electrophysiology. 10(12). 2741–2743.
2.
Wang, Chen-Yu, Lv Liu, Hong Peng, & Hong Luo. (2024). A nonsense mutation (c.382C>T) of PARN in a patient with idiopathic pulmonary fibrosis. QJM. 117(8). 605–607. 1 indexed citations
3.
Ren, Yi, Peng Huang, Lu Zhang, et al.. (2024). Dual Regulation Mechanism of Obesity: DNA Methylation and Intestinal Flora. Biomedicines. 12(8). 1633–1633. 2 indexed citations
4.
Peng, Hong, et al.. (2024). Loss of ZNF451 mediates fibroblast activation and promotes lung fibrosis. Respiratory Research. 25(1). 160–160. 1 indexed citations
5.
Cheng, Wei, Chengming Fan, Qing Song, et al.. (2023). Induced pluripotent stem cell-based therapies for organ fibrosis. Frontiers in Bioengineering and Biotechnology. 11. 1119606–1119606. 5 indexed citations
6.
Song, Min Sup, et al.. (2023). CSE regulates LINC000665/XBP-1 in the progress of pulmonary fibrosis. Tobacco Induced Diseases. 21(December). 1–10. 1 indexed citations
7.
Guo, Ting, Qinxue Shen, Jinhua Li, et al.. (2021). Clinical Findings in Diabetes Mellitus Patients with COVID-19. Journal of Diabetes Research. 2021. 1–7. 13 indexed citations
8.
Guo, Ting, et al.. (2021). Clinical profiles of SS-ILD compared with SS-NILD in a Chinese population: a retrospective analysis of 735 patients. Annals of Medicine. 53(1). 1340–1348. 11 indexed citations
9.
Guo, Ting, et al.. (2021). Cofilin-1 promotes fibrocyte differentiation and contributes to pulmonary fibrosis. Biochemical and Biophysical Research Communications. 565. 43–49. 8 indexed citations
10.
Liu, Lv, Ting Guo, Ping Chen, et al.. (2020). Identification and functional characterization of a novel surfactant protein A2 mutation (p.N207Y) in a Chinese family with idiopathic pulmonary fibrosis. Molecular Genetics & Genomic Medicine. 8(9). e1393–e1393. 6 indexed citations
11.
Guo, Ting, Qinxue Shen, Zhiguo Zhou, et al.. (2020). <p>Combined Interventions for Severe Novel Coronavirus Disease (COVID-19): Experience from 350 Patients</p>. Infection and Drug Resistance. Volume 13. 3907–3918. 2 indexed citations
12.
Guo, Ting, Qinxue Shen, Wei Guo, et al.. (2020). Clinical Characteristics of Elderly Patients with COVID-19 in Hunan Province, China: A Multicenter, Retrospective Study. Gerontology. 66(5). 467–475. 98 indexed citations
13.
Shen, Qinxue, Ting Guo, Min‐Keun Song, et al.. (2020). Pain is a common problem in patients with ILD. Respiratory Research. 21(1). 297–297. 5 indexed citations
14.
Song, Min Sup, Shan Cai, Hong Luo, et al.. (2019). Short-term pulmonary infiltrate with eosinophilia caused by asthma: a phenotype of severe, eosinophilic asthma? Five cases and a review of the literature. Allergy Asthma and Clinical Immunology. 15(1). 48–48. 2 indexed citations
15.
Song, Min Sup, Hong Peng, Man Luo, et al.. (2019). Cigarette Smoke Extract Promotes Human Lung Myofibroblast Differentiation by the Induction of Endoplasmic Reticulum Stress. Respiration. 98(4). 347–356. 25 indexed citations
16.
Peng, Xueyan, Meagan W. Moore, Hong Peng, et al.. (2014). CD4+CD25+FoxP3+ Regulatory Tregs inhibit fibrocyte recruitment and fibrosis via suppression of FGF-9 production in the TGF-β1 exposed murine lung. Frontiers in Pharmacology. 5. 80–80. 37 indexed citations
17.
Reilkoff, Ronald A., Hong Peng, Lynne A. Murray, et al.. (2012). Semaphorin 7a+ Regulatory T Cells Are Associated with Progressive Idiopathic Pulmonary Fibrosis and Are Implicated in Transforming Growth Factor-β1–induced Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 187(2). 180–188. 97 indexed citations
18.
Peng, Hong & Erica L. Herzog. (2012). Fibrocytes: emerging effector cells in chronic inflammation. Current Opinion in Pharmacology. 12(4). 491–496. 63 indexed citations
19.
Peng, Hong. (2010). Establishment and Assessment of a Mouse Model of Cigarette Smoke-Induced Emphysema. 1 indexed citations
20.
Peng, Hong, Ping Chen, Ying Cai, et al.. (2007). Endothelin-1 increases expression of cyclooxygenase-2 and production of interlukin-8 in hunan pulmonary epithelial cells. Peptides. 29(3). 419–424. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chengping Hu Breakdown of academic impact, for papers by Shanping Jiang Breakdown of academic impact, for papers by Katherine Ma O’Reilly Breakdown of academic impact, for papers by Alexandra C. Racanelli Breakdown of academic impact, for papers by Shijie Wang Breakdown of academic impact, for papers by Mahmood Yaseen Hachim Breakdown of academic impact, for papers by Rui Tian Breakdown of academic impact, for papers by Zeng‐Hong Wu Breakdown of academic impact, for papers by Bihong Zhao Breakdown of academic impact, for papers by Zongwen Shuai
Rankless by CCL
2026